| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1528-1157.1968.TB04954.X |
| P698 | PubMed publication ID | 4386877 |
| P2093 | author name string | Kristensen M | |
| Hansen JM | |||
| Skovsted L | |||
| P433 | issue | 1 | |
| P304 | page(s) | 17-22 | |
| P577 | publication date | 1968-03-01 | |
| P1433 | published in | Epilepsia | Q5382969 |
| P1476 | title | Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism. | |
| P478 | volume | 9 |
| Q89338655 | 4-Amino-2,3-dihydro-1λ6-isothiazole-1,1-dioxides and their chemical properties evaluation |
| Q38094502 | Acute Toxicity of Antiepileptic Drugs |
| Q40142216 | Anticonvulsant drugs. An update |
| Q52736150 | Anticonvulsant drugs. I. Patho-physiological and pharmacological aspects. |
| Q39956570 | Anticonvulsant drugs. II. Clinical pharmacological and therapeutic aspects. |
| Q34359667 | Antiepileptic Drugs: Biotransformation, Metabolism, and Serum Half-Life |
| Q40265358 | Antiepileptic therapeutic drug monitoring. |
| Q93528796 | Any Questions? |
| Q72450245 | Changes in Regional Brain Levels of Amino Acid Putative Neurotransmitters After Prolonged Treatment with t he Anticonvulsant Drugs Diphenylhydantoin, Phenobarbitone, Sodium Valproate, Ethosuximide, and Sulthiame in the Rat |
| Q52490830 | Changes in the velocity of drug catabolism and their importance in drug therapy |
| Q28362813 | Choreo-athetosis and encephalopathy induced by phenytoin |
| Q42230509 | Control of long-term therapy with diphenylhydantoin. Gas-chromatographic determination of diphenylhydantoin and hydroxy-diphenylhydantoin |
| Q93698420 | Cranial neuropathies and diabetes |
| Q40427478 | Design of clinical antiepileptic drug trials |
| Q43222657 | Differential effect of continuous administration of beta-adrenoceptor antagonists on antipyrine and phenytoin clearance. |
| Q69944336 | Drug enzyme induction and drug interactions: Literature tabulation |
| Q40640589 | Drug interactions and clinical pharmacokinetics |
| Q39554942 | Drug interactions that matter. A critical reappraisal |
| Q40300215 | Drug interactions with phenytoin |
| Q39620912 | Drugs and children: methods for therapeutic monitoring |
| Q40096573 | Effect of drugs on electroclinical types of epileptic seizures in Lennox-Gastaut syndrome |
| Q37053483 | Effect of sodium valproate on plasma protein binding of diphenylhydantoin |
| Q93698423 | Folic acid and phenytoin metabolism |
| Q71839609 | Folic acid and the half-life of diphenylhydantoin in man |
| Q67211676 | Inhibition of drug metabolism by chloramphenicol |
| Q34451296 | Inhibition of phenytoin metabolism by sulthiame in epileptic patients |
| Q69351369 | Interaction between Doxycycline and some Antiepileptic Drugs |
| Q43904085 | Interaction between sulthiame and clobazam: sulthiame inhibits the metabolism of clobazam, possibly via an action on CYP2C19. |
| Q43241793 | Interaction of phenytoin with chlorpheniramine [letter] |
| Q39336953 | Interactions of Antiepileptic Drugs |
| Q36493244 | Interactions with Antiepileptic Drugs |
| Q28323344 | Involuntary movements caused by phenytoin intoxication in epileptic patients |
| Q70004842 | Letter: Phenytoin intoxication caused by sulthiame |
| Q39935532 | Measurement of Therapeutic Agents in Blood |
| Q48697102 | Metabolic interactions of phenytoin in the rat: Effect of coadministration with the anticonvulsant drugs sodium valproate, sulthiame, ethosuximide or phenobarbital |
| Q71290781 | Monotherapy antiepileptic drug trials in patients undergoing presurgical assessment: methodological problems and possibilities |
| Q61822540 | PRENATAL DIAGNOSIS OF TAY-SACHS DISEASE |
| Q37909318 | Pharmacokinetic drug interactions with phenytoin (Part II). |
| Q40329711 | Pharmacokinetic interactions with antiepileptic drugs |
| Q44673846 | Pharmacokinetics of single and multiple doses of phenytoin in man |
| Q34063156 | Pharmacologic therapy of ventricular arrhythmias |
| Q37097628 | Phenytoin intoxication induced by sulthiame in epileptic patients |
| Q54301689 | Phenytoin teratogenicity in man. |
| Q40164017 | Phenytoin: Basic and clinical pharmacology |
| Q35600619 | Proceedings: Evidence for a dopaminergic mechanism for modulation of adrenergic transmission in the rabbit ear artery |
| Q42254694 | Proceedings: Inhibition of phenytoin metabolism by sulthiame. |
| Q40083637 | Psychopharmacological aspects of antiepileptic treatment |
| Q34146451 | Sulthiame in adults with refractory epilepsy and learning disability: an open trial. |
| Q72532494 | Sulthiame in previously untreated epilepsy |
| Q39390251 | The Effect of Different Oral Anticoagulants on Diphenylhydantoin (DPH) and Tolbutamide Metabolism |
| Q40585193 | The Effect of Different Sulfonamides on Phenytoin Metabolism in Man |
| Q37070680 | The distribution of plasma phenytoin levels in epileptic patients |
| Q67826142 | The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man |
| Q33620992 | The interaction of denzimol (a new anticonvulsant) with carbamazepine and phenytoin |
Search more.